EXCHANGE TRADED CONCEPTS, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 289 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2024. The put-call ratio across all filers is 1.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
EXCHANGE TRADED CONCEPTS, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,503,225
+56.5%
77,046
+21.4%
0.06%
+53.7%
Q1 2024$1,599,187
+10.8%
63,485
+42.8%
0.04%
+5.1%
Q4 2023$1,443,671
+21.0%
44,448
+1.5%
0.04%
+14.7%
Q3 2023$1,193,522
+4516.2%
43,807
+3670.0%
0.03%
+3300.0%
Q2 2023$25,855
+0.7%
1,162
-1.9%
0.00%0.0%
Q1 2023$25,667
+4.2%
1,185
-2.3%
0.00%0.0%
Q4 2022$24,636
-25.3%
1,213
-5.6%
0.00%0.0%
Q3 2022$33,000
+22.2%
1,285
+14.3%
0.00%0.0%
Q2 2022$27,000
+17.4%
1,124
+8.1%
0.00%
Q1 2022$23,000
-95.9%
1,040
-96.3%
0.00%
-100.0%
Q4 2021$562,000
+4.1%
28,365
+3.4%
0.01%
-21.4%
Q3 2021$540,000
-34.1%
27,438
-26.4%
0.01%
-46.2%
Q2 2021$820,000
+3.8%
37,279
+12.3%
0.03%
-13.3%
Q1 2021$790,000
-23.7%
33,190
-16.2%
0.03%
-37.5%
Q4 2020$1,036,000
+66.6%
39,591
+10.9%
0.05%
+37.1%
Q3 2020$622,000
-1.6%
35,715
-5.0%
0.04%
-66.7%
Q2 2020$632,00037,6010.10%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2024
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,360,485$186,0218.91%
Novo Holdings A/S 3,377,768$75,155,3385.81%
Parallel Advisors, LLC 3,726,565$82,916,0712.67%
TANAKA CAPITAL MANAGEMENT INC 35,539$7912.14%
S&T BANK/PA 347,260$7,7271.39%
FAS Wealth Partners, Inc. 310,771$6,914,6550.88%
Birchview Capital, LP 50,000$1,112,5000.83%
Granite Investment Partners, LLC 792,519$17,633,5480.70%
Bridge City Capital, LLC 60,632$1,349,0620.64%
AJ WEALTH STRATEGIES, LLC 509,934$11,346,0320.55%
View complete list of CORCEPT THERAPEUTICS INC shareholders